Stephens Consulting »

Recursion Pharmaceuticals shares owned by Stephens Consulting

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Stephens Consulting from 13F filings

Historical chart of Stephens Consulting investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Stephens Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Stephens Consulting

Quarter filed Position value Share count Share price at filing
2025-09-30 $327 67 4.88
2025-06-30 $339 67 5.07
2025-03-31 $989 187 5.29
2024-12-31 $453 67 6.76